title: Safety of ciprofloxacin in children with cystic fibrosis.
authors.affiliation: Department of Pediatrics, University of Pittsburgh School of Medicine, Pennsylvania.
authors.forename: D M
authors.initials: DM
authors.lastname: Orenstein
authors.forename: E N
authors.initials: EN
authors.lastname: Pattishall
authors.forename: B E
authors.initials: BE
authors.lastname: Noyes
authors.forename: G
authors.initials: G
authors.lastname: Kurland
authors.forename: E R
authors.initials: ER
authors.lastname: Hartigan
authors.forename: V L
authors.initials: VL
authors.lastname: Yu
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D002648:Child; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced; D008171:Lung Diseases / Q000188:drug therapy* / Q000382:microbiology*; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D012449:Safety
chemical_list: D002939:Ciprofloxacin; D000469:Alkaline Phosphatase; D012293:Rifampin